Literature DB >> 3683586

Synthesis of the skeleton of the morphine molecule by mammalian liver.

C J Weitz1, K F Faull, A Goldstein.   

Abstract

The possibility that morphine could be synthesized in animals has long been considered and a pathway in mammalian brain analogous to that in the opium poppy has been proposed. Substances have been detected in mammalian brain that are recognized by antisera raised against morphine. Recently we reported the presence of three such immunoreactive substances in bovine hypothalamus and adrenal, and in rat brain, and the definitive identification of two of them by gas chromatography-mass spectrometry as morphine and codeine. Incorporation of a labelled precursor has demonstrated the biosynthesis of morphine in the opium poppy from tyrosine-derived units (see Fig. 1). Intramolecular coupling of reticuline to form salutaridine is the critical step that generates the morphine skeleton (morphinan) and the stereochemistry of the morphinan series. We now report the conversion in vivo and in vitro of reticuline to salutaridine by rat liver, but this conversion is not detectable in rat brain and bovine adrenal. This is the first direct demonstration of the synthesis of a morphinan in an animal tissue and also supports the hypothesis that morphine and codeine in brain and adrenal are of endogenous origin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3683586     DOI: 10.1038/330674a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  18 in total

Review 1.  Characterizing proteins of unknown function: orphan cytochrome p450 enzymes as a paradigm.

Authors:  F Peter Guengerich; Zhongmei Tang; S Giovanna Salamanca-Pinzón; Qian Cheng
Journal:  Mol Interv       Date:  2010-06

2.  How human neuroblastoma cells make morphine.

Authors:  Chotima Boettcher; Monika Fellermeier; Christian Boettcher; Birgit Dräger; Meinhart H Zenk
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

3.  Single-dose and steady-state kinetics of morphine and its metabolites in cancer patients--a comparison of two oral formulations.

Authors:  J Hasselström; N Alexander; C Bringel; J O Svensson; J Säwe
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

5.  Cytochrome P450 3A Enzymes Catalyze the O6-Demethylation of Thebaine, a Key Step in Endogenous Mammalian Morphine Biosynthesis.

Authors:  Valerie M Kramlinger; Mónica Alvarado Rojas; Tatsuyuki Kanamori; F Peter Guengerich
Journal:  J Biol Chem       Date:  2015-07-08       Impact factor: 5.157

6.  Mammalian cytochrome P450 enzymes catalyze the phenol-coupling step in endogenous morphine biosynthesis.

Authors:  Nadja Grobe; Baichen Zhang; Ursula Fisinger; Toni M Kutchan; Meinhart H Zenk; F Peter Guengerich
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

7.  [Do benzodiazepines represent "natural" drugs?].

Authors:  U Klotz
Journal:  Klin Wochenschr       Date:  1989-01-20

8.  Identification of the convulsant opiate thebaine in mammalian brain.

Authors:  H Kodaira; C A Lisek; I Jardine; A Arimura; S Spector
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 9.  Benzodiazepines in the brain. Their origin and possible biological roles.

Authors:  J H Medina; C Peña; M Piva; C Wolfman; M L de Stein; C Wasowski; C Da Cunha; I Izquierdo; A C Paladini
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

10.  Endogenous morphine levels are increased in sepsis: a partial implication of neutrophils.

Authors:  Elise Glattard; Ingeborg D Welters; Thomas Lavaux; Arnaud H Muller; Alexis Laux; Dan Zhang; Alexander R Schmidt; François Delalande; Benoît-Joseph Laventie; Sylvie Dirrig-Grosch; Didier A Colin; Alain Van Dorsselaer; Dominique Aunis; Marie-Hélène Metz-Boutigue; Francis Schneider; Yannick Goumon
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.